Skip to content

Headspace program improved anxiety and depression symptoms compared with a waitlist

A remote randomized trial found symptom improvements that persisted at follow-up. It did not compare the app with psychotherapy, medication, or another active treatment.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Participants assigned to the Headspace program showed greater improvements in anxiety and depression symptoms over time than people on the waitlist. Benefits persisted at the short follow-up, and combined anxiety and depression remission was more common in the app group. Because the comparator was a waitlist, this trial cannot establish equivalence to established treatments or superiority over them.

Keep in mind

This abstract-based summary is limited by short follow-up and the absence of an active treatment comparator. The abstract does not define the thresholds for its combined remission outcome.

THE RESULT, WITH CONTEXT

What researchers found

Greater improvement

Anxiety and depression questionnaire scores

Headspace versus waitlist across baseline, program completion, and 3-week follow-up. Statistical tests detected different symptom changes over time between groups.

JMIR Mhealth Uhealth, 2025 · Original source ↓

What was tested

The program combined cognitive behavioral and mindfulness strategies in short daily app sessions. Participants were selected for elevated anxiety or depression symptoms, and researchers assessed symptom questionnaires alongside sleep, stress, mindfulness, and well-being.

What else was reported

Sleep quality, stress, mindfulness, and mental well-being also improved in the app group. No serious adverse events were reported, but that observation and the short follow-up do not establish longer-term safety.

CHECK THE ORIGINAL

The original publication

Efficacy of a Self-Guided Transdiagnostic Intervention for Adults With Anxiety and Depression: Randomized Controlled Trial.

Staiano W, Callahan CE, Davis M et al.
JMIR Mhealth Uhealth · 2025

PubMed ID
41129814
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.